{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:46:56Z","timestamp":1789724816097,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,4,29]],"date-time":"2012-04-29T00:00:00Z","timestamp":1335657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10620-012-2187-3","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T04:52:59Z","timestamp":1335588779000},"page":"2423-2429","source":"Crossref","is-referenced-by-count":94,"title":["Tenofovir Disoproxil Fumarate for Prevention of Vertical Transmission of Hepatitis B Virus Infection by Highly Viremic Pregnant Women: A Case Series"],"prefix":"10.1007","volume":"57","author":[{"given":"Calvin Q.","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalermrat","family":"Bunchorntavakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Karsdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,29]]},"reference":[{"key":"2187_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2010.12.030","volume":"55","author":"SJ Hadziyannis","year":"2011","unstructured":"Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55:183\u2013191. doi: 10.1016\/j.jhep.2010.12.030 .","journal-title":"J Hepatol"},{"key":"2187_CR2","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1046\/j.1440-1746.2000.02096.x","volume":"15","author":"MH Chang","year":"2000","unstructured":"Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol. 2000;15:E16\u2013E19.","journal-title":"J Gastroenterol Hepatol"},{"key":"2187_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771\u2013774. doi: 10.1056\/nejm197504102921503 .","journal-title":"N Engl J Med"},{"key":"2187_CR4","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0016-5085(87)90614-7","volume":"92","author":"NC Tassopoulos","year":"1987","unstructured":"Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology. 1987;92:1844\u20131850.","journal-title":"Gastroenterology"},{"key":"2187_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","volume":"190","author":"E Wiseman","year":"2009","unstructured":"Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190:489\u2013492.","journal-title":"Med J Aust"},{"key":"2187_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","volume":"16","author":"WM Xu","year":"2009","unstructured":"Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94\u2013103. doi: 10.1111\/j.1365-2893.2008.01056.x .","journal-title":"J Viral Hepat"},{"key":"2187_CR7","doi-asserted-by":"crossref","unstructured":"Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55:1215\u20131221. doi: 10.1016\/j.jhep.2011.02.032 .","DOI":"10.1016\/j.jhep.2011.02.032"},{"key":"2187_CR8","doi-asserted-by":"crossref","unstructured":"Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepatitis. 2012;19:e18\u2013e25. doi: 10.1111\/j.1365-2893.2011.01492.x .","DOI":"10.1111\/j.1365-2893.2011.01492.x"},{"key":"2187_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/14740330903241584","volume":"8","author":"D Nurutdinova","year":"2009","unstructured":"Nurutdinova D, Overton ET. A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV. Expert Opin Drug Saf. 2009;8:683\u2013694. doi: 10.1517\/14740330903241584 .","journal-title":"Expert Opin Drug Saf"},{"key":"2187_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","volume":"116","author":"Z Shi","year":"2010","unstructured":"Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:147\u2013159. doi: 10.1097\/AOG.0b013e3181e45951 .","journal-title":"Obstet Gynecol"},{"key":"2187_CR11","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol. 2009;50:227\u2013242. doi: 10.1016\/j.jhep.2008.10.001 .","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"2187_CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u2013662. doi: 10.1002\/hep.23190 .","journal-title":"Hepatology"},{"key":"2187_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/apc.2008.0263","volume":"23","author":"S Baroncelli","year":"2009","unstructured":"Baroncelli S, Tamburrini E, Ravizza M, et al. Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes. AIDS Patient Care STDS. 2009;23:513\u2013520. doi: 10.1089\/apc.2008.0263 .","journal-title":"AIDS Patient Care STDS"},{"key":"2187_CR14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-1293.2009.00709.x","volume":"10","author":"C Foster","year":"2009","unstructured":"Foster C, Lyall H, Olmscheid B, Pearce G, Zhang S, Gibb DM. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? HIV Med. 2009;10:397\u2013406. doi: 10.1111\/j.1468-1293.2009.00709.x .","journal-title":"HIV Med"},{"key":"2187_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11901-010-0059-x","volume":"9","author":"NH Bzowej","year":"2010","unstructured":"Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hepat Rep. 2010;9:197\u2013204. doi: 10.1007\/s11901-010-0059-x .","journal-title":"Curr Hepat Rep"},{"key":"2187_CR16","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0264-410X(97)00080-7","volume":"15","author":"R Canho del","year":"1997","unstructured":"del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982\u20131992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15:1624\u20131630.","journal-title":"Vaccine"},{"key":"2187_CR17","first-page":"966A","volume":"52","author":"LJ Mi","year":"2009","unstructured":"Mi LJ, Karsdon J, Huang WM, et al. Hepatitis B virus transmission rate among children born to Chinese-American mothers with chronic hepatitis B in the New York downtown area. Hepatology. 2009;52:966A.","journal-title":"Hepatology"},{"key":"2187_CR18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359:2442\u20132455. doi: 10.1056\/NEJMoa0802878 .","journal-title":"N Engl J Med"},{"key":"2187_CR19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132\u2013143. doi: 10.1053\/j.gastro.2010.10.011 .","journal-title":"Gastroenterology"},{"key":"2187_CR20","unstructured":"The Antiretroviral Pregnancy Registry: Interim Report for 1 January 1989 to 31 January 2011; 2011. Available at http:\/\/www.apregistry.com ."},{"key":"2187_CR21","first-page":"505a","volume":"52","author":"LJ Mi","year":"2010","unstructured":"Mi LJ, Karsdon J, Huang WM, et al. Outcomes of eight Chinese-Americans pregnant patients with chronic hepatitis B (CHB) treated with tenofovir DF (TDF) during pregnancy. Hepatology. 2010;52:505a.","journal-title":"Hepatology"},{"key":"2187_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042560-200203010-00001","volume":"29","author":"AF Tarantal","year":"2002","unstructured":"Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr. 2002;29:207\u2013220.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2187_CR23","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","volume":"118","author":"RI Gafni","year":"2006","unstructured":"Gafni RI, Hazra R, Reynolds JC, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics. 2006;118:e711\u2013e718. doi: 10.1542\/peds.2005-2525 .","journal-title":"Pediatrics"},{"key":"2187_CR24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpeds.2007.12.020","volume":"152","author":"JB Purdy","year":"2008","unstructured":"Purdy JB, Gafni RI, Reynolds JC, Zeichner S, Hazra R. Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus. J Pediatr. 2008;152:582\u2013584. doi: 10.1016\/j.jpeds.2007.12.020 .","journal-title":"J Pediatr"},{"key":"2187_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3851\/IMP1813","volume":"16","author":"M Giles","year":"2011","unstructured":"Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther. 2011;16:621\u2013628. doi: 10.3851\/imp1813 .","journal-title":"Antivir Ther"},{"key":"2187_CR26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1345\/aph.1L083","volume":"42","author":"D Nurutdinova","year":"2008","unstructured":"Nurutdinova D, Onen NF, Hayes E, Mondy K, Overton ET. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants. Ann Pharmacother. 2008;42:1581\u20131585. doi: 10.1345\/aph.1L083 .","journal-title":"Ann Pharmacother"},{"key":"2187_CR27","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00350-08","volume":"52","author":"KK Rompay Van","year":"2008","unstructured":"Van Rompay KK, Durand-Gasselin L, Brignolo LL, et al. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother. 2008;52:3144\u20133160. doi: 10.1128\/aac.00350-08 .","journal-title":"Antimicrob Agents Chemother"},{"key":"2187_CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","volume":"136","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Gane E, Leung N, et al. 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology. 2009;136:486\u2013495. doi: 10.1053\/j.gastro.2008.10.026 .","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-012-2187-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2187-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T21:06:38Z","timestamp":1594069598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2187-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,29]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2187-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,29]]}}}